Want to see IN:BAYERCROP full AI Analyst Report?
Bayer Cropscience India Limited (BAYERCROP) Stock Price & Analysis
BAYERCROP Stock Chart & Stats
- Day’s Range
- INR 3,290.00 - INR 3,318.30
- 52-Week Range
- INR 3,224.90 - INR 5,055.00
- Previous Close
- INR 3,249.85
- Volume
- N/A
- Average Volume (3M)
- 4,705
- Market Cap
- INR 146.06B
- Enterprise Value
- INR 158.33B
- Total Cash (Recent Filing)
- INR 14.72B
- Total Debt (Recent Filing)
- INR 0
- Price to Earnings (P/E)
- 19.9
- Beta
- 0.95
- Next Earnings
- Feb 14, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Nov 12, 2026
- Dividend Yield
- 4.54%
Bulls Say, Bears Say
Bulls Say
Very Low Leverage
The exceptionally low debt burden gives Bayer Cropscience India substantial financial flexibility and reduces interest-related pressure. Its steadily expanding equity base also provides a durable buffer to support operations, absorb volatility, and fund future growth without relying heavily on borrowing.
Long-Term Revenue Growth
Revenue expansion across FY2021-FY2026 indicates that the company has increased the scale of its crop science franchise over time. Broader sales across crop protection, seeds, and related solutions can strengthen operating relevance and support sustained reinvestment in the Indian agriculture market.
Strong FY2026 Cash Conversion
Free cash flow close to net income in FY2026 supports the quality of reported earnings and shows that profitability converted effectively into cash. This strengthens the company’s ability to fund dividends, working capital, and strategic initiatives from internal resources when operating conditions are supportive.
Bears Say
Margin Compression
Although profitability remains solid, the decline in net margins from FY2023-FY2024 shows that earnings growth has not been fully protected from pressure. Sustained compression could reduce reinvestment capacity and make future profit expansion more dependent on renewed operating improvement.
Volatile Cash Generation
Historical variability in operating and free cash flow makes the company’s cash-generation profile less predictable than its FY2026 rebound alone suggests. Uneven conversion can complicate dividend, working-capital, and investment planning, particularly across differing agricultural business cycles.
Inconsistent Returns On Equity
Lower returns on equity in FY2025 suggest that profitability has not consistently scaled with the company’s growing equity base. If this pattern persists, capital may be deployed less efficiently and the business could require stronger earnings growth to maintain attractive shareholder returns.
BAYERCROP FAQ
What was Bayer Cropscience India Limited’s price range in the past 12 months?
What is Bayer Cropscience India Limited’s market cap?
When is Bayer Cropscience India Limited’s upcoming earnings report date?
How were Bayer Cropscience India Limited’s earnings last quarter?
Is Bayer Cropscience India Limited overvalued?
Does Bayer Cropscience India Limited pay dividends?
What is Bayer Cropscience India Limited’s EPS estimate?
How many shares outstanding does Bayer Cropscience India Limited have?
What happened to Bayer Cropscience India Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Bayer Cropscience India Limited?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Bayer Cropscience India Limited
Bayer CropScience Limited, founded in Thane, India, in 1958, is a diversified enterprise involved in various sectors, including agriculture, pharmaceuticals, and consumer health, with a global reach encompassing India, Germany, and Bangladesh, among other international markets. The company's agricultural segment is dedicated to the manufacturing, sales, and distribution of an extensive array of crop protection products, such as insecticides, fungicides, and herbicides, alongside other specialized agrochemicals. It also provides hybrid seeds, including corn and paddy varieties, to agriculturalists. In the pharmaceutical domain, Bayer CropScience delivers medicines primarily targeting cardiology, gynecology, diabetes, oncology, and ophthalmology. Additionally, it supplies advanced diagnostic imaging technologies, such as computed tomography (CT), X-ray, and magnetic resonance imaging (MRI) equipment, together with essential contrast agents. Its consumer health division offers a selection of products designed for daily wellness and the management of minor ailments. Pioneering digital solutions for farming, the company provides platforms like FarmRiseTM and other predictive systems. These tools integrate and analyze vast amounts of data from sources such as farm machinery, satellites, field sensors, irrigation networks, and drones. Leveraging data science and sophisticated predictive analytics, these systems furnish farmers with actionable insights to optimize their decision-making. The company also actively exports its comprehensive range of products.
- Sector
- General
- Industry
- Agricultural Inputs
- CEO
- Simon-Thorsten Wiebusch
- Employees
- 1,317
- Website
- www.bayer.in
- Address
- Bayer House, Thane, MA, 400607, IN
Bayer Cropscience India Limited (BAYERCROP) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 4 | 13 |
| Technical Analysis | 2 | 4 | 4 |
| Moving Averages | 3 | 0 | 9 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:DHANUKADhanuka Agritech Limited | ||
| IN:PIINDPI Industries Limited | ||
| IN:RALLISRallis India Limited | ||
| IN:SHARDACROPSharda Cropchem Ltd. | ||
| IN:UPLUPL Limited |
